雙美

0.00 (–)最後更新 2026-09-11

台灣 · 上櫃 · 生技醫療業

–0成交張數26.24本益比14.88股價淨值比3.09%殖利率2026-09-11資料日期

ROE 與 ROA

近四季合計;近十年

每股淨值

元

負債比率

負債總額 / 資產總額

現金流量

單季,億元;自由現金流 = 營業現金流 + 資本支出(負值)

季度	資產總額(億)	母公司權益(億)	負債比率	流動比率	每股淨值	ROE(近四季)	ROA(近四季)	營業現金流(億)	自由現金流(億)
2026Q2	20	14	28.5%	2.55	26.27	60.7%	37.0%	2.7	2.7
2026Q1	24	12	50.2%	1.34	21.78	63.1%	30.9%	2.7	2.4
2025Q4	21	16	23.8%	3.89	29.70	46.4%	34.4%	2.6	2.2
2025Q3	19	14	23.9%	3.85	26.52	51.0%	38.1%	1.6	1.5
2025Q2	24	12	47.9%	1.50	22.85	57.4%	29.2%	1.3	1.3
2025Q1	23	11	51.9%	1.33	20.36	53.5%	31.4%	2.7	2.7
2024Q4	21	15	27.8%	3.32	27.78	46.2%	31.9%	2.4	2.3
2024Q3	19	14	26.8%	3.40	25.10	53.1%	36.6%	1.0	0.9
2024Q2	24	12	50.2%	1.41	21.88	62.9%	30.3%	0.6	0.5
2024Q1	23	16	30.9%	2.57	29.52	44.0%	31.1%	1.6	1.5
2023Q4	22	14	34.0%	2.36	26.18	45.5%	31.7%	2.3	1.8
2023Q3	20	13	35.2%	2.01	23.22	47.2%	32.3%	1.9	1.7
2023Q2	23	11	53.3%	1.26	19.70	50.1%	26.5%	1.9	1.8
2023Q1	20	15	27.4%	2.53	26.68	40.4%	29.2%	2.4	2.1
2022Q4	18	13	26.1%	2.78	24.33	45.5%	32.6%	1.6	1.4
2022Q3	17	12	27.4%	2.50	22.04	47.6%	31.8%	1.5	1.2
2022Q2	17	11	39.0%	1.68	19.45	40.0%	25.6%	1.4	0.9
2022Q1	16	12	28.3%	2.74	21.43	29.8%	20.7%	1.9	1.4
2021Q4	15	10	31.0%	2.36	18.79	25.7%	17.3%	-0.4	-1.4
2021Q3	15	9	39.5%	2.05	16.99	26.0%	16.4%	1.4	0.3
2021Q2	15	10	32.4%	2.98	18.24	29.5%	19.3%	0.6	0.3
2021Q1	14	10	33.2%	3.22	17.45	35.1%	24.4%	0.8	0.6
2020Q4	14	9	34.8%	3.28	16.32	29.5%	19.3%	1.6	0.7
2020Q3	12	8	33.8%	3.66	14.79	26.3%	17.8%	1.4	1.0
2020Q2	12	7	37.0%	3.42	13.41	23.0%	14.8%	1.1	1.1
2020Q1	10	7	26.5%	5.55	13.38	17.1%	12.7%	-0.2	-0.3
2019Q4	11	7	33.9%	4.26	13.36	22.0%	16.3%	1.0	1.0
2019Q3	10	7	30.1%	5.42	12.75	22.4%	17.2%	0.5	0.5
2019Q2	10	7	34.2%	4.06	12.19	19.8%	14.6%	0.9	0.9
2019Q1	9	7	24.2%	10.32	12.67	15.0%	12.2%	0.4	0.4
2018Q4	8	6	14.5%	8.11	11.90	12.2%	10.5%	0.5	0.4
2018Q3	7	6	13.0%	9.46	11.31	8.4%	7.4%	0.1	0.1
2018Q2	7	6	15.1%	7.72	11.13	6.9%	6.1%	0.3	0.3
2018Q1	7	6	11.8%	28.02	10.85	5.0%	4.5%	0.1	0.1
2017Q4	7	6	13.4%	17.60	10.52	2.9%	2.6%	0.1	0.1
2017Q3	6	6	9.2%	23.58	10.41	4.3%	4.0%	0.2	0.2
2017Q2	6	6	7.5%	23.26	10.30	4.3%	4.0%	0.2	0.2
2017Q1	6	6	7.1%	25.07	10.17	0.3%	0.3%	-0.1	-0.1
2016Q4	6	6	7.1%	25.31	10.20	–	–	0.2	0.2
2016Q3	6	5	6.9%	29.86	9.98	–	–	0.1	0.1